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Abstract
Background: In regions of declining malaria transmission, new strategies for control are needed to reduce transmission and
achieve elimination. Artemisinin-combination therapy (ACT) is active against immature gametocytes and can reduce the risk
of transmission. We sought to determine whether household screening and treatment of infected individuals provides
protection against infection for household members.
Methodology/Principal Findings: The study was conducted in two areas in Southern Province, Zambia in 2007 and 2008/
2009. To determine the impact of proactive case detection, households were randomly selected either to join a longitudinal
cohort, in which participants were repeatedly screened throughout the year and those infected treated with artemether-
lumefantrine, or a cross-sectional survey, in which participants were visited only once. Cross-sectional surveys were
conducted throughout the year. The prevalence of RDT positivity was compared between the longitudinal and cross-
sectional households at baseline and during follow-up using multilevel logistic regression. In the 2007 study area, 174 and
156 participants enrolled in the cross-sectional and longitudinal groups, respectively. In the 2008/2009 study area, 917 and
234 participants enrolled in the cross-sectional and longitudinal groups, respectively. In both study areas, participants and
households in the longitudinal and cross-sectional groups were similar on demographic characteristics and prevalence of
RDT positivity at baseline (2007: OR=0.97; 95% CI:0.46, 2.03 | 2008/2009: OR=1.28; 95% CI:0.44, 3.79). After baseline, the
prevalence of RDT positivity was significantly lower in longitudinal compared to cross-sectional households in both study
areas (2007: OR=0.44; 95% CI:0.20, 0.96 | 2008/2009: OR=0.16; 95% CI:0.05, 0.55).
Conclusions/Significance: Proactive case detection, consisting of screening household members with an RDT and treating
those positive with ACT, can reduce transmission and provide indirect protection to household members. A targeted test
and treat strategy could contribute to the elimination of malaria in regions of low transmission.
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Introduction
An estimated 225 million cases of malaria and 781,000 deaths
occurred worldwide in 2009, with the majority in the African
region [1]. In the past decade, international support and funding
for malaria control increased dramatically and targets were set to
increase coverage of interventions to over 80% by 2010, reduce
the burden of malaria by 75% by 2015 [1], and eliminate malaria
in 8–10 countries by 2015 [1]. This renewed commitment to
malaria elimination has been made possible with increased
coverage of four key interventions: insecticide-treated nets (ITNs),
indoor residual spraying (IRS) of targeted households, treatment
with artemisinin-combination therapy (ACT), and intermittent
preventive treatment for high-risk groups including pregnant
women and infants. Programs that have achieved high coverage
with these interventions have shown dramatic decreases in the
number of malaria cases, admissions and deaths [1,2,3,4], and 11
African countries have demonstrated large (.50%) and sustained
decreases in the burden of malaria [1].
Several case detection strategies have been implemented in
regions affected by malaria [5]. Many programs rely on
identification of symptomatic individuals at healthcare facilities
(passive case detection). However, the prevalence of asymptomatic
or minimally symptomatic parasitemia in a population can be as
high as 35% [6,7,8,9]. As these individuals do not exhibit
symptoms severe enough to seek care, their infections go
untreated, thereby serving as parasite reservoirs that can maintain
transmission. Consequently, additional strategies are needed,
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strategy is to screen individuals for parasitemia and provide
treatment to those who are infected (proactive case detection or
focal screening and treatment) [10], thereby identifying and
treating asymptomatic or minimally symptomatic individuals. Use
of ACT can enhance this strategy as it is active against immature
gametocytes [11]. Treatment not only reduces the burden of
parasites within the individual but can reduce the risk of
transmission to mosquitoes [12,13]. In regions of declining
transmission, the burden of malaria could potentially be reduced
to such an extent that elimination is achievable.
Using a series of longitudinal and cross-sectional household
surveys in a setting of declining malaria transmission in southern
Zambia, we sought to quantify the effect of proactive case
detection by screening individuals within households and treating
those infected with ACT. We hypothesized that the prevalence of
infection would be lower in households in the longitudinal cohort
where individuals were repeatedly tested and treated compared to
households in the cross-sectional surveys where individuals were
tested and treated once.
Methods
The study was approved the University of Zambia Research
Ethics Committee and the Institutional Review Board at the Johns
Hopkins Bloomberg School of Public Health.
Study design
This study was conducted within the context of an epidemio-
logic study to determine changes in the prevalence of parasitemia
and gametocytemia in a region of unstable malaria transmission in
southern Zambia [14,15]. To determine the impact of proactive
case detection, households were randomly selected either to join a
longitudinal cohort, in which participants were repeatedly
screened throughout the year and those infected treated with
ACT, or a cross-sectional survey, in which participants were
visited only once. A series of cross-sectional surveys was conducted
throughout the year to account for any temporal and seasonal
changes in transmission.
Study site
The study was conducted in the catchment area of Macha
Hospital in Choma District, Southern Province, Zambia between
April 2007 and December 2009. Macha Hospital is located
approximately 70 km from the nearest town of Choma on a
plateau at an altitude of approximately 1,100 meters above sea
level and in a habitat characterized as Miombo woodland. There
is a single rainy season from approximately November through
April, followed by a cool, dry season from April to August, and a
hot, dry season from August to November. The catchment area is
populated by traditional villagers living in small, scattered
homesteads. Anopheles arabiensis is the primary vector responsible
for malaria transmission [16], which peaks during the rainy
season.
The Southern Province of Zambia historically had hyperen-
demic transmission of Plasmodium falciparum [17]. More recently,
the entomological inoculation rate for An. arabiensis was estimated
to range from 1.6 to 18.3 infective bites per person per season [16]
and the number of children hospitalized for malaria decreased
dramatically (unpublished data). Zambia introduced artemether-
lumefantrine as antimalarial therapy in 2002, and insecticide-
treated bed nets (ITNs) were widely distributed in Southern
Province, Zambia in 2007 [14]. Widespread IRS has not been
formally conducted in the study area.
The study site in 2007 consisted of a 525 km
2 region east of
Macha Hospital (Figure 1). In 2008 and 2009, the study site was
shifted to an adjacent 575 km
2 area west of the 2007 study site and
closer to Macha Hospital. This was done for logistical reasons as
distances to the study households proved to be difficult to navigate
operationally, particularly during the rainy season when roads and
bridges were flooded.
Randomization
At the beginning of the study in each site, satellite images were
used to construct a sampling frame for the random selection of
households to be enrolled in a prospective longitudinal cohort
study and serial cross-sectional surveys. The sampling frame was
constructed from a Quickbird
TM satellite image obtained from
DigitalGlobe Services, Inc. (Denver, Colorado). The image was
imported into ArcGIS 9.2 (Redlands, CA) and locations of
households were identified and enumerated manually. In this area,
households consist of one or more domestic structures where
members of a family or extended family reside. Operationally,
structures of appropriate size and shape situated within cleared
sections of land approximately 50 meters wide were identified as
potential residences from the satellite image. Satellite images have
been used successfully to establish a sampling frame in Zambia
[18]. The desired number of households was randomly selected
from the sampling frame to be enrolled in the longitudinal cohort
study. From the remaining households, the desired number of
households was randomly selected without replacement to be
enrolled in each of the cross-sectional surveys conducted
throughout the calendar year. Random selection was performed
to ensure as much as possible that longitudinal and cross-sectional
households were comparable at baseline.
Study procedures
Study procedures were the same for households enrolled in the
longitudinal cohort and cross-sectional surveys and began with
community mobilization activities, including approvals from local
chiefs and headmen. A field team was provided with images and
coordinates of the randomly selected households. All individuals
within a household were enumerated and were eligible to
participate. Permission was obtained from the head of household
and written informed consent was obtained from each individual
present in the household. The consent process included a
description of their participation in either the longitudinal cohort
or cross-sectional survey. Not all participants in a household were
required to participate.
During each study visit, a questionnaire was administered to
each consenting participant older than 18 years of age residing
within the household and to parents or guardians of those younger
than 18 years of age. Data collected included demographic
information, history of recent malaria and antimalarial treatment,
knowledge of malaria transmission and prevention, and the use of
ITNs. Participant’s temperature was measured using a Braun
ThermoscanH ear thermometer. A blood sample was collected by
finger prick from consenting participants for a rapid diagnostic test
(RDT) for malaria. The RDT (ICT Diagnostics, Cape Town,
South Africa) detected P. falciparum histidine-rich protein 2 and was
shown to detect 82% of test samples with wild-type P. falciparum at
a concentration of 200 parasites/mL and 98% of test samples with
a concentration of 2000 parasites/mL, with false positives in 0.6%
of negative samples [19]. Individuals who were RDT positive were
offered treatment with artemether-lumefantrine (CoartemH) ac-
cording to national guidelines.
Households selected for the longitudinal cohort were repeat-
edly surveyed approximately five times per calendar year
Household Screening and Treatment for Malaria
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replacement households were randomly selected from the
sampling frame. In 2007 and 2008, the target sample size for
the cohort was approximately 17 households. At the end of 2008,
additional households were selected to increase the sample size to
24 in 2009.
Households selected for each cross-sectional survey were visited
only once. Cross-sectional surveys were carried out approximately
five times per calendar year. The target sample size for each cross
sectional survey was the same as the target sample size per month
of the corresponding cohort. For logistical reasons, the longitudi-
nal and cross-sectional surveys were conducted in alternating
months beginning April 2007 and February 2008.
Statistical methods
The primary endpoint was the point prevalence of RDT
positivity in the household. Analyses were conducted at two time
points: 1) at baseline to determine whether the prevalence of RDT
positivity differed between longitudinal and cross-sectional house-
holds at the first study visit prior to antimalarial treatment; and 2)
during follow-up to determine whether the prevalence of RDT
positivity differed between the longitudinal households throughout
follow-up (with continued exposure to treatment of RDT positive
individuals) and the cross-sectional households. For the baseline
analysis, all study visits for participants in the cross-sectional
households but only the first study visit for participants in the
longitudinal households were included. For the follow-up analysis,
all study visits for participants in the cross-sectional households
were included but, for participants in the longitudinal households,
the first study visit was excluded and only subsequent study visits
were included.
For the primary analysis at both baseline and follow-up, logistic
regression with a random intercept for households and robust
standard error estimation was used to estimate the odds ratio of
RDT positivity for the longitudinal compared to the cross-
sectional households as randomized. Within-participant clustering
was considered during follow-up, as participants in longitudinal
households contributed multiple visits. However, the within-
participant, intraclass correlation coefficient (ICC) was low
(ICC=0.00002); therefore, only within-household clustering is
reported. Transmission season, high or low, was included in the
models to account for temporal changes, and was defined based on
rainfall data and pediatric hospitalizations for malaria at Macha
Hospital during the study periods. Within a calendar year, the
high transmission season was assumed to occur from January 1 to
June 30 and from November 1 to December 31. For the 2008/
2009 study period, season was defined across calendar years, such
that high transmission seasons occurred from January 1 to June
Figure 1. Map of the study sites in Choma district, Southern province, Zambia.
doi:10.1371/journal.pone.0031396.g001
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December 31, 2009. As RDT positivity was relatively common in
2007, the analysis was repeated using Poisson regression with
robust standard error estimation (Table S1), which yielded similar
inferences.
As a secondary analysis at both baseline and follow-up,
multilevel logistic regression with a random intercept for
households and robust standard error estimation was used to
explore the contribution of individual and household level baseline
characteristics. A two-level model was fit with individuals (level 1)
nested within households (level 2). Both individual-level (e.g. age,
sex, ITN use) and household-level (e.g. housing type, season)
covariates that differed (p,0.10) between groups at baseline were
considered for inclusion in the models.
Results
Characteristics of the study population at the first study
visit
In the 2007 study area, 174 participants from 34 households
were enrolled in the cross-sectional group and 156 participants
from 18 households were enrolled in the longitudinal group
(Table 1 and 2; Figure 2). The characteristics of participants in
each group were similar in terms of sex (% male: longitudi-
Figure 2. Study flow diagram for 2007 and 2008/2009. HH: household.
doi:10.1371/journal.pone.0031396.g002
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years: L:25.6%; C:21.1%; p=0.30), and education (% adults with
some secondary education: L:81.4%; C:70.4%; p=0.35). The
majority of participants did not own an ITN (L:61.5%; C:56.9%;
p=0.36). Participants differed significantly on their reporting of
antimalarial use in the prior 2 weeks (L:12.2%; C:4.6%; p=0.03),
recent visit to a health center or post for an illness (L:50.0% less
than one month ago; C:31.0%; p=0.01) and for their last febrile
episode (L:57.1%; C:30.5%; p,0.0001), and sleeping under an
ITN at the time of the visit, among participants who owned an
ITN (L:70.0%; C:25.3%; p,0.0001).
In the 2008/2009 study area, 917 participants from 166
households were enrolled in the cross-sectional group and 234
participants from 29 households were enrolled in the longitu-
dinal group (Table 1 and 2; Figure 2). The characteristics of
participants in each group were also similar in terms of sex (%
male: L:47.4%; C:47.8%; p=0.92), age (% ,5 years: L:21.6%;
C:19.4%; p=0.52), and education (% adults with some
secondary education: L:66.7%; C:65.1%; p=0.62). Longitudi-
nal and cross-sectional participants differed in their ownership
(L:79.1% with $1 ITN; C:66.1%; p=0.0003) and use of ITNs
(L:63.2%; C:55.3%; p=0.06), and their use of health services
for their last febrile episode (L:53.9%; C:63.9%; p=0.005).
Comparison of RDT positivity between cross-sectional
and longitudinal groups at the first study visit prior to
treatment exposure
In the 2007 study area, 41 participants (23.6%) from 21
households (61.8%) were RDT positive in the cross-sectional
group, and 38 participants (24.4%) from 14 households (77.8%)
were RDT positive in the longitudinal group (Figure 3A). Among
cross-sectional households with at least one RDT positive
individual, the median number of positive individuals was 2
(IQR:1, 3) for a median household prevalence of 30.0%
(IQR:25.0, 50.0). Among longitudinal households with at least
one RDT positive individual, the median number of positive
Table 1. Participant characteristics at the initial study visit by year.
2007 2008&2009
Cross-sectional
N( % )
Longitudinal
N (%) p-value
b
Cross-sectional
N( % )
Longitudinal
N (%) p-value
b
Number of participants 174 156 917 234
Male sex 87 (50.0) 66 (42.3) 0.16 438 (47.8) 111 (47.4) 0.93
Median age 13.1 (5.6, 34.7) 12.7 (4.9, 27.6) 0.26 14.3 (6.6, 34.1) 13.0 (5.6, 24.2) 0.13
0–4 36 (21.1) 40 (25.6) 176 (19.4) 50 (21.6)
5–17 67 (39.2) 57 (36.5) 356 (39.2) 95 (41.0)
$18 71 (40.8) 59 (37.8) 0.56 383 (41.9) 89 (38.0) 0.54
Education (among participants $18 years)
, Grade 1 2 (2.8) 1 (1.7) 15 (3.8) 5 (5.8)
Grade 1–6 19 (26.8) 10 (17.0) 122 (31.1) 24 (27.6)
Grade 7–12, or higher 50 (70.4) 48 (81.4) 0.35 255 (65.1) 58 (66.7) 0.62
Number of ITN in the household
0 99 (56.9) 96 (61.5) 311 (33.9) 49 (20.9)
1 48 (27.6) 44 (28.2) 542 (59.1) 171 (73.1)
$2 27 (15.5) 16 (10.3) 0.36 64 (7.0) 14 (6.0) 0.0003
Sleeps under ITN, among participants with ITN 19 (25.3) 42 (70.0) ,0.0001 335 (55.3) 117 (63.2) 0.06
ITN ever treated, among those sleeping under ITN 2 (10.5) 11 (26.2) 0.21 63 (18.8) 34 (29.1) 0.10
House has ever been sprayed with insecticide 3 (1.7) 3 (1.9) 0.63 14 (1.5) 6 (2.6) 0.28
Used any antimalarial medication in last 2 wks 8 (4.6) 19 (12.2) 0.03 29 (3.2) 5 (2.1) 0.41
Presence of any symptoms in last 48 hours
a 128 (73.6) 93 (59.6) 0.01 543 (59.2) 135 (57.7) 0.67
Self-reported fever in the last 48 hrs 72 (41.4) 51 (32.7) 0.10 218 (23.8) 61 (26.1) 0.46
Fever ($38uC) 7 (4.1) 7 (4.5) 0.83 16 (1.7) 2 (0.9) 0.33
Visited health post/center/hospital for last fever 53 (30.5) 89 (57.1) ,0.0001 586 (63.9) 126 (53.9) 0.005
Last visited a health center or post for an illness
,=1 month ago 54 (31.0) 78 (50.0) 336 (36.6) 71 (30.3)
2–6 months ago 52 (29.9) 34 (21.8) 275 (30.0) 86 (36.8)
.6 months ago 46 (26.4) 32 (20.5) 171 (18.7) 41 (17.5)
Do not know 22 (12.6) 12 (7.7) 0.01 135 (14.7) 36 (15.4) 0.17
RDT positive 41 (23.6) 38 (24.4) 0.87 36 (3.9) 10 (4.3) 0.81
ITN: insecticide-treated net.
aSymptoms included fever, chills, headache, diarrhea, cough, nausea/vomiting.
bComparison of cross-sectional and longitudinal participants using the chi-square test for binary characteristics and the Wilcoxon ranksum test for continuous
characteristics.
doi:10.1371/journal.pone.0031396.t001
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of 33.3% (IQR:12.5, 44.4). In both groups, the majority of
infections were in children younger than 15 years. Only 10% of
individuals who were RDT positive had a documented fever at the
study visit, with the majority of symptomatic infections occurring
among children 5–17 years of age.
In the primary analysis, no differences in the odds of RDT
positivity were observed between households in the longitudinal
cohort and cross-sectional surveys (odds ratio [OR]:0.97; 95%
CI:0.46, 2.03) (Table 3). Some clustering of RDT positivity was
observed within households (ICC:0.17; s:0.81). Adjusting for
season decreased the OR to 0.59 (95% CI:0.25, 1.39; ICC:0.17;
s:0.83), although this result was not statistically significant.
In the 2008/2009 study area, 36 participants (3.9%) from 23
households (13.9%) were RDT positive in the cross-sectional
group, and 10 participants (4.3%) participants from 7 households
(24.1%) were RDT positive in the longitudinal group (Figure 3B).
Among cross-sectional households with at least one RDT positive
individual, the median number of positive individuals was 1
(IQR:1, 1) for a median household prevalence of 20.0%
(IQR:14.3, 33.3). Among longitudinal households with at least
one RDT positive individual, the median number of positive
individuals was 1 (IQR:1, 2) for a median household prevalence of
12.5% (IQR:11.1, 18.2). In both groups, the majority of infections
were in children younger than 15 years. Only 15% of individuals
who were RDT positive had a documented fever at the study visit,
with the majority of symptomatic infections occurring among
children 5–17 years of age.
In the primary analysis, no differences in the odds of RDT
positivity were observed between households in the longitudinal
cohort and cross-sectional surveys (OR:1.28; 95% CI:0.44, 3.79;
ICC:0.40; s:1.47) (Table 3). Similar to the findings in 2007,
adjusting for season decreased the OR to 0.90 (95% CI:0.31, 2.65;
ICC:0.35; s:1.32), although this result was not statistically
significant.
In both study areas, accounting for individual and household
level characteristics at baseline did not significantly impact the
results (Table 3).
Comparison of RDT positivity between cross-sectional
and longitudinal groups during follow-up
In the 2007 study area, 174 participants from 34 households in
the cross-sectional group and 126 participants from 17 households
in the longitudinal group after their first visit were included in the
analysis. Longitudinal participants contributed a median of 2 study
Table 2. Household characteristics at the initial study visit by year.
2007 2008&2009
Cross-sectional
N( % )
Longitudinal
N (%) p-value
a
Cross-sectional
N( % )
Longitudinal
N (%) p-value
a
Number of households 34 18 166 29
Median number of participants per household
(range)
5 (1–11) 8 (3–19) 0.006 5 (1–21) 8 (2–15) ,0.0001
Source of water
Private well or pump 2 (5.9) 3 (16.7) 2 (1.2) 1 (3.5)
Public well, pump or standpipe 19 (55.9) 11 (61.1) 100 (60.2) 15 (51.7)
River or stream 12 (35.3) 2 (11.1) 37 (22.3) 6 (20.7)
Unprotected well 1 (2.9) 2 (11.1) 0.14 27 (16.3) 7 (24.1) 0.57
Toilet
Pit latrine 16 (47.1) 8 (44.4) 120 (72.3) 15 (51.7)
No facility/bush/field 18 (52.9) 9 (50.0) 46 (27.7) 14 (48.3)
Other 0 (0.0) 1 (5.6) 0.38 0 (0.0) 0 (0.0) 0.03
Source of light
Candle 4 (11.8) 0 (0.0) 27 (16.3) 0 (0.0)
Lantern 28 (82.4) 17 (94.4) 117 (70.5) 27 (93.1)
Other 2 (5.9) 1 (5.6) 0.31 22 (13.3) 2 (6.9) 0.03
Material of floor
Cement 13 (38.2) 5 (27.8) 35 (21.1) 5 (17.2)
Earth 21 (61.8) 13 (72.2) 0.45 131 (78.9) 24 (82.8) 0.64
Material of walls
Fired brick/cement 28 (82.4) 16 (88.9) 148 (89.2) 27 (93.1)
Other 6 (17.7) 2 (11.1) 0.53 18 (10.8) 2 (6.9) 0.52
Material of roof
Iron sheets/corrugated tin 9 (26.5) 3 (16.7) 44 (26.5) 8 (27.6)
Pole and grass 23 (67.7) 13 (72.2) 119 (71.7) 20 (69.0)
Other 2 (5.9) 2 (11.1) 0.62 3 (1.8) 1 (3.5) 0.84
aComparison of cross-sectional and longitudinal households using the chi-square test for binary characteristics and the Wilcoxon ranksum test for continuous
characteristics.
doi:10.1371/journal.pone.0031396.t002
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doi:10.1371/journal.pone.0031396.g003
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times (range:1, 4). In the longitudinal group, 38 infections were
detected during follow-up from 33 individuals (three with 2 RDT
positive results and one with 3 RDT positive results) in 10
households. The participants with multiple positive RDTs were all
5 years of age or younger. Individuals with positive RDTs within
the same household were primarily found on the same study visit.
In the primary analysis, the odds of RDT positivity were
significantly lower for households in the longitudinal group after
the first visit compared to the cross-sectional households (OR:0.44;
95% CI:0.20, 0.96; ICC:0.18; s:0.86) (Table 3; Figure 4A) and the
results remained significant after adjusting for season (OR:0.37;
95% CI:0.16, 0.88; ICC:0.22; s:0.98).
In the 2008/2009 study area, 917 participants from 166
households in the cross-sectional group and 190 participants
from 29 households in the longitudinal group after their first
visit were included in the analysis. Longitudinal participants
contributed a median of 3 study visits (range:1, 11) and
households were surveyed a median of 10 times (range:1, 11).
In the longitudinal group, six infections were detected during
follow-up from six individuals in five households. The two
infections in the same household were detected on different
visits.
In the primary analysis, the odds of RDT positivity were
significantly lower for households in the longitudinal group
after the first visit compared to the cross-sectional households
(OR:0.16; 95% CI:0.05, 0.55; ICC:0.39; s:1.44) (Table 3;
Figure 4B). The results remained significant after adjusting for
season (OR:0.13; 95% CI:0.04, 0.41; ICC:0.30; s:1.19). There
w a ss o m ee v i d e n c eo fal o w e r i n go ft h eh o u s e h o l dm a l a r i ar i s k
over time as the odds ratio for RDT positivity was lower in
subsequent follow-up visits in the longitudinal households
compared to the cross-sectional households, suggesting a
cumulative effect (first visit: crude OR=0.44; 95% CI=0.10,
1.93; second visit: OR=0.15; 95% CI=0.02, 1.45; third visit:
OR=0.16; 95% CI=0.02, 1.61).
In both study areas, accounting for individual and household
level characteristics at baseline did not significantly impact the
results (Table 3).
Discussion
We sought to quantify the effect of a proactive strategy of
household screening and treatment with ACT of individuals
infected with Plasmodium falciparum on the reduction in malaria
transmission within households. The prevalence of parasitemia
was significantly reduced in households repeatedly screened and
treated compared to a control group of households. This effect
was consistent across two geographic areas with different levels of
malaria transmission. Strategies to reduce and interrupt malaria
transmission through treatment of symptomatic and asymptom-
atic infections are possible with the use of ACT. Artemisinin
derivatives are active against both young and mature asexual
parasites and immature gametocytes [11], thus preventing
gametocyte development and blocking transmission to mosqui-
toes. Studies have shown that gametocyte carriage is significantly
reduced among individuals treated with artemisinin derivatives in
comparison to other antimalarials [11,13,20,21,22]. Artemisinin-
based derivatives also have been shown to decrease both
transmission to mosquitoes and the prevalence of high density
oocyst infections within mosquitoes [12,13].
In areas where malaria transmission has declined following
implementation of effective control measures, additional strate-
gies are needed to identify and treat asymptomatic or minimally
symptomatic cases to eliminate reservoirs of infection, interrupt
transmission and achieve elimination [5]. Several case detection
strategies have been developed and implemented. Passive case
detection, involving identification of symptomatic patients
seeking care at health facilities, requires the least resources.
This strategy, however, does not detect asymptomatic or
minimally symptomatic infections as these individuals will not
present to health care facilities. The proportion of malaria cases
that are asymptomatic or minimally symptomatic is substantial
Table 3. Comparison of RDT positivity between longitudinal and cross-sectional households at the initial study visit and during
follow-up, by study year.
2007 2008 and 2009
Primary Analysis OR (95% CI) ICC OR (95% CI) ICC
Comparison at the initial study visit
a
Crude model 0.97 (0.46, 2.03) 0.17 1.28 (0.44, 3.79) 0.40
Adjusted for season
b 0.59 (0.25, 1.39) 0.17 0.90 (0.31, 2.65) 0.35
Comparison during follow-up
a
Crude model 0.44 (0.20, 0.96) 0.18 0.16 (0.05, 0.55) 0.39
Adjusted for season
b 0.37 (0.16, 0.88) 0.22 0.13 (0.04, 0.41) 0.30
Secondary Analysis
Comparison at the initial study visit
a
Adjusted for season and other baseline individual and household characteristics
c 0.57 (0.21, 1.53) 0.25 0.85 (0.28, 2.54) 0.34
Comparison during follow-up
a
Adjusted for season and other baseline individual and household characteristics
c 0.32 (0.13, 0.80) 0.25 0.12 (0.04, 0.39) 0.31
aComparison at initial study visit included all participants in the cross-sectional group and the first study visit for participants in the longitudinal group; comparison
during follow-up included all participants in the cross-sectional group and excluded the first study visit for participants in the longitudinal group.
bFor 2007, the transmission season was defined as Jan-Jun and Jul-Oct; for 2008/2009, the transmission season was defined as Jan-Jun 2008, Jul-Oct 2008, Nov 2008-Jun
2009, Jul-Oct 2009, and Nov-Dec 2009.
cFor 2007, other baseline characteristics included age, sleeping under an ITN and taking an antimalarial in the last 2 weeks; for 2008/2009, other baseline characteristics
included age, sleeping under an ITN, type of toilet and source of light.
doi:10.1371/journal.pone.0031396.t003
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majority of infectious cases would be missed with passive case
detection. Reactive case detection [5] extends this strategy based
on the observation that malaria cases are spatially clustered and
that cases identified at health centers (index cases) represent foci
of infection within households and surrounding neighborhoods.
With reactive case detection, residents of households of index
cases and possibly of households in the immediate vicinity are
screened and treated if found to be infected. However, little data
exist on the appropriate radius from the index household that
should be screened, and this radius likely varies in different
epidemiological settings. In a study of reactive case detection in
rural southern Zambia, the prevalence of malaria was found to
be significantly higher among residents of households of index
cases than among residents of randomly selected households in
the area [25]. However, even with reactive case detection, many
infectious cases would be missed. In our community-based study,
only 10–15% of RDT positive individuals were symptomatic
with a documented fever and up to 70% of individuals reported
they did not seek care for their last febrile episode. Consequently,
most infected participants would have been missed through
reactive case detection. In 2007, 79 individuals from 35
households were RDT positive at the first study visit; however,
only 16 residents of 10 households reported fever and sought
care. If these cases sought care and their households were
screened, as in reactive case detection, 38 RDT positive
individuals would have been detected, representing only 52%
of all RDT positive individuals. In 2008/2009, the proportion of
RDT positive individuals who would have gone undetected
increased to 72%.
A second strategy to target asymptomatic or minimally
symptomatic individuals is mass drug distribution, in which case
detection is not attempted and drugs are distributed to a
population regardless of symptoms and without diagnosis of
infection. Mass drug distribution has a long history in malaria
control, achieving transient reductions in incidence or prevalence
but with little effect on transmission [26].
Lastly, a case detection strategy more intensive than passive or
reactive case detection, but without treating the entire popula-
tion, is proactive case detection [5], where populations are
screened and infected individuals are treated (‘‘test and treat’’) as
was done in this study. This strategy requires substantial
resources for personnel and drugs, a rapid diagnostic test with
a high positive predictive value, and a non-mobile population
w i l l i n gt oa c c e p ts c r e e n i n ga n dt r e a t m e n to fm i n i m a l l y
symptomatic individuals. Proactive case detection may be an
essential strategy to achieve elimination in regions of sub-
Saharan Africa where the burden of malaria has been
substantially reduced with current control efforts. Proactive case
detection has successfully been implemented in Morocco [27],
Brazil [28], Taiwan [29], and Southern China [30], where levels
of malaria transmission are lower than in much of sub-Saharan
Africa. However, these studies evaluated the success of proactive
case detection based on the burden of malaria before and after
implementation of a case detection program, without concurrent
control groups.
To our knowledge, this is the first formal quantification of the
effect size of proactive case detection with ACT using a
concurrent comparison group. Although the findings were
consistent in two adjacent areas with different levels of malaria
transmission, the reduction in malaria prevalence appeared to be
greater in the study area with a lower level of transmission
intensity. Proactive case detection resulted in a six-fold reduction
in prevalence in 2008/2009, where the initial parasite prevalence
was 4%, but in only a two-fold reduction in 2007, where the
initial prevalence was 24%, suggesting that proactive case
detection may have greater impact on malaria transmission in
areas where current control measures have succeeded in reducing
transmission. These results are consistent with the predicted
impact of artemisinin-based therapies in different transmission
settings [31].
This study had several limitations. First, as a trial could not be
conducted for ethical reasons, this observational study was
designed as a cohort study with a series of cross-sectional studies
for comparison. Households enrolled in the longitudinal cohort
study were repeatedly surveyed and it is possible that the
behaviors of household residents were influenced by participation
in the study. Indeed, ITN use during follow-up was higher for
individuals in the cohort compared to the cross-sectional surveys,
particularly during the low transmission season (data not shown).
Consequently, it is possible that the effect of proactive case
detection was overestimated in longitudinal households. In
addition, despite the random selection of households, differences
between the cross-sectional and longitudinal households and their
residents were identified at baseline that may have impacted their
risk of malaria, including ownership and use of ITNs. These
differences in ITN use were primarily attributable to the seasons
in which the longitudinal (high transmission) and cross-sectional
(high and low transmission) households were enrolled and were
not apparent after adjustment (data not shown). However, the
decreased odds of RDT positivity in the longitudinal households
at baseline after adjusting for season may indicate that the effect
of proactive case detection during follow-up was overestimated.
Second, for ethical reasons all RDT positive individuals in both
the cross-sectional and longitudinal groups were treated with
ACT. Given the potential for ACT to reduce malaria
transmission, there may have been an indirect protective effect
conferred to residents living in proximity to households where
participants were treated. Consequently, the impact of this
strategy may have been underestimated. Lastly, the sensitivity of
the RDT decreases at lower parasite densities [19], and infections
in individuals with low levels of parasitemia could have been
missed. We do not expect this misclassification to have occurred
differentially between participants in longitudinal and cross-
sectional households, and therefore the effect of this strategy may
have been underestimated.
In summary, proactive case detection with treatment using
ACT can reduce transmission and provide indirect protection to
household members. If resources permit, this strategy could be
targeted to focal areas of transmission within regions in the pre-
elimination phase of malaria control to achieve further reductions
in malaria transmission.
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